HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ketan Gajjar Selected Research
Ketan Gajjar Research Topics
Disease
4
Neoplasms (Cancer)
01/2019 - 10/2012
3
Ovarian Neoplasms (Ovarian Cancer)
04/2014 - 12/2012
2
Pain (Aches)
07/2016 - 10/2012
2
Carcinogenesis
12/2012 - 11/2012
1
Surgical Wound Infection
01/2019
1
Endometrial Neoplasms (Endometrial Cancer)
07/2013
1
Glioma (Gliomas)
09/2012
1
Lacerations
10/2009
1
Breech Presentation
10/2009
Drug/Important Bio-Agent (IBA)
2
Prilocaine Drug Combination Lidocaine
FDA Link
Generic
07/2016 - 10/2012
2
Analgesics (Analgesic Drugs)
IBA
07/2016 - 10/2012
2
Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
IBA
07/2016 - 10/2012
2
Benzocaine (Americaine)
FDA Link
07/2016 - 10/2012
2
Vasoconstrictor Agents
IBA
07/2016 - 10/2012
2
Prilocaine (Citanest)
FDA Link
Generic
07/2016 - 10/2012
2
Cocaine (Cocaine HCl)
IBA
07/2016 - 10/2012
2
Felypressin
IBA
07/2016 - 10/2012
2
Desflurane (I 653)
FDA Link
07/2016 - 10/2012
2
Isoflurane
FDA Link
Generic
07/2016 - 10/2012
2
Lidocaine (Xylocaine)
FDA Link
Generic
07/2016 - 10/2012
2
Epinephrine (Adrenaline)
FDA Link
Generic
07/2016 - 10/2012
2
N 30
IBA
04/2014 - 07/2013
2
Hormones (Hormone)
IBA
12/2012 - 11/2012
1
Buffers
IBA
07/2016
1
Solutions
IBA
07/2016
1
Sodium Bicarbonate (Baking Soda)
FDA Link
Generic
07/2016
1
Xenobiotics
IBA
12/2012
1
Cytochromes
IBA
12/2012
1
Cytochrome P-450 Enzyme System (Cytochrome P450)
IBA
12/2012
1
Environmental Carcinogens
IBA
11/2012
1
Enzymes
IBA
11/2012
1
Carcinogens
IBA
11/2012
1
Cholesterol Esters (Cholesteryl Esters)
IBA
09/2012
1
Phenylalanine (L-Phenylalanine)
FDA Link
09/2012
Therapy/Procedure
2
Analgesia
07/2016 - 10/2012
2
Laser Therapy (Surgery, Laser)
07/2016 - 10/2012
2
Cryosurgery
07/2016 - 10/2012
2
Transcutaneous Electric Nerve Stimulation (TENS)
07/2016 - 10/2012
2
Lasers (Laser)
07/2016 - 10/2012
1
Operative Surgical Procedures
01/2019
1
Laparotomy
01/2019
1
Cesarean Section (Caesarean Section)
10/2009